FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

428527002: Human tetanus immunoglobulin (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3993305015 Human tetanus immunoglobulin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3993306019 Human tetanus immunoglobulin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
59251000195112 immunoglobulina umana antitetanica it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
320991000077117 immunoglobuline antitétanique humaine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
74531000195119 Tetanus-Immunglobulin vom Menschen de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Human tetanus immunoglobulin Is a Tetanus immunoglobulin (substance) true Inferred relationship Some
Human tetanus immunoglobulin Is a Human immunoglobulin (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Tetanus antitoxin, human The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human tetanus immunoglobulin Inferred relationship Some
Product containing human tetanus immunoglobulin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Human tetanus immunoglobulin Inferred relationship Some 1
flacon d'une solution injectable de 250 UI d'immunoglobuline antitétanique The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human tetanus immunoglobulin Inferred relationship Some
flacon d'une solution pour perfusion de 2500 UI d'immunoglobuline antitétanique The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human tetanus immunoglobulin Inferred relationship Some
seringue préremplie avec solution injectable de 250 UI d'immunoglobuline antitétanique The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Human tetanus immunoglobulin Inferred relationship Some
Administration of human tetanus immune globulin (procedure) Direct substance False Human tetanus immunoglobulin Inferred relationship Some 3
Administration of human tetanus immune globulin (procedure) Direct substance True Human tetanus immunoglobulin Inferred relationship Some 1
Intramuscular injection of human tetanus immunoglobulin Direct substance True Human tetanus immunoglobulin Inferred relationship Some 1
Product containing only human tetanus immunoglobulin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Human tetanus immunoglobulin Inferred relationship Some 1
Product containing human tetanus immunoglobulin in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Human tetanus immunoglobulin Inferred relationship Some 1
Product containing only human tetanus immunoglobulin in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Human tetanus immunoglobulin Inferred relationship Some 1
Product containing precisely human tetanus immunoglobulin 250 unit/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Human tetanus immunoglobulin Inferred relationship Some 1
Product containing precisely human tetanus immunoglobulin 250 unit/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Human tetanus immunoglobulin Inferred relationship Some 1
Product containing precisely human tetanus immunoglobulin 100 unit/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Human tetanus immunoglobulin Inferred relationship Some 1
Product containing precisely human tetanus immunoglobulin 100 unit/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Human tetanus immunoglobulin Inferred relationship Some 1

This concept is not in any reference sets

Back to Start